Panacea Biotec Pharma is a finished-dose manufacturer based in India. It appears in 104 regulatory filings across 15 regulators, without an active US DMF or CEP on file. Its filings concentrate with TMDA (TZ), ARCSA (EC) and JFDA (JO). Its GMP standing is certified by EMA, NAFDAC (NG) and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 12 October 2023 as OAI. Customs aggregates show $15.2M of exports covering 482 molecules to 43 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Baddi, United Arab Emirates | Not on file |
| Solan, India | 3007187282 |
| BADDI, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| TMDA (TZ) | 29 | None |
| ARCSA (EC) | 14 | None |
| JFDA (JO) | 11 | None |
| UZPHARM (UZ) | 9 | None |
| MINSA (CR) | 8 | None |
| DAV (Vietnam) | 7 | None |
| EMA | None | 3 |
| NAFDAC (NG) | None | 1 |
| ANVISA (Brazil) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $15.2M | 43 |
| 2024 | Not reported | $17.4M | 41 |
| 2023 | Not reported | $19.5M | 35 |
| 2022 | Not reported | $15.1M | 36 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Panacea Biotec Pharma comes back tiered against every other supplier able to file there.
Start for free